'Short' drug-resistant TB regimen could cut treatment time by more than half - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

The number of pills an MDR-TB patient would have to take could be reduced from an average of 14 000 to an average of 3 360 over the course of treatment.from nearly two years to nine to 11 months with a similar effectiveness, according to a large clinical trial whose results were published in a US journal on Wednesday.

The new clinical trial, which included nearly 400 patients from Vietnam, Mongolia, South Africa and Ethiopia , compared the effectiveness of long-term treatment and that of a shorter therapy. In reducing the length of treatment, patients have a better chance of finishing the entire regimen, especially in poor countries where healthcare infrastructures are weak.

This is progress..💝

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novel TB treatment ups patients’ oddsNew compound that was developed by TB Alliance, used with Pfizer products, cured 90% of patients in study Is the reference to Pfizer in this article an error? Bedaquiline is from JNJGlobalHealth. Linezolid is an old drug. Pretomanid is TBAlliance.
Source: BDliveSA - 🏆 12. / 63 Read more »

HEALTH-E NEWS: South Africa bids to regain WHO polio-free certificationSouth Africa is part of a ‘pariah’ group of countries that are not certified polio-free, thanks to weaknesses in our surveillance and vaccination programme. The Department of Health is determined to win back its certificate in April, and it launched an immunisation survey last week to check on the nation’s vaccination rate. But we should never have lost the certificate in the first place.
Source: dailymaverick - 🏆 3. / 84 Read more »